Personalised Cancer Vaccine

Personalised mRNA Cancer Vaccine Cuts Melanoma Recurrence Risk by 42% in Major Clinical Trial

HIT AND HOT NEWS Desk November 2, 2026 0

A promising development in cancer research has brought personalised medicine into the spotlight after an experimental mRNA-based vaccine significantly reduced...

Personalised mRNA Cancer Vaccine Cuts Melanoma Recurrence Risk by 42% in Major Clinical Trial

False Nuclear and Chemical Warnings Appear on Ukrainian Phones

Two Separate Strikes Reported in Gaza

Qatar Steps Up Diplomatic Efforts as Strait of Hormuz Crisis Threatens Global Stability

Personalised mRNA Cancer Vaccine Cuts Melanoma Recurrence Risk by 42% in Major Clinical Trial

Intensive Diet and Exercise Programme Helps 54% of Younger Adults Achieve Type 2 Diabetes Remission in Six Months

You may have missed